Clinical Trials Logo

Clinical Trial Summary

This study aims to assess usual walking speed (4-metre gait speed) and markers of sarcopenia predict mortality in patients with chronic respiratory disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02261337
Study type Observational
Source Royal Brompton & Harefield NHS Foundation Trust
Contact
Status Completed
Phase
Start date December 2013
Completion date April 2022

See also
  Status Clinical Trial Phase
Completed NCT01630200 - Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT02571582 - Predictors of Mortality in Patients With Advanced Lung Disease in Home Oxygen Therapy N/A